- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02902250
The Comparative Study About the Effect of Vertebral Body Decompression Procedure
January 3, 2023 updated by: Jin S. Yeom, Seoul National University Hospital
The Comparative Study About the Effect of Vertebral Body Decompression Procedure and Conservative Treatment for Benign Vertebral Compression Fracture - Prospective Randomized Control Study
The purpose of this study is to compare the treatment efficacy between vertebral body decompression procedure and conservative treatment with non-inferiority design
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gyounggido
-
Seongnam-si, Gyounggido, Korea, Republic of
- Seoul National University Bundang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- osteoporotic vertebral compression fracture
Exclusion Criteria:
- malignancy or inflammatory disease
- severe pain in other joints
- coagulopathy
- an inappropriate person considered by investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Decompression
bone marrow decompression at fractured vertebral body
|
vertebral body decompression in compression fracture
|
|
Active Comparator: Conservative Treatment
Conservative Treatment for compression fracture
|
Conservative Treatment in vertebral compression fracture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Pain Scale
Time Frame: until 3 months after procedure
|
Pain status
|
until 3 months after procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oswestry Disability Index
Time Frame: until 3 months after procedure
|
Health status
|
until 3 months after procedure
|
|
EQ5D-5L
Time Frame: until 3 months after procedure
|
Quality of Life
|
until 3 months after procedure
|
|
Leed Dyspepsia Questionnaire
Time Frame: until 3 months after procedure
|
Abdominal discomfort d/t medication and injection
|
until 3 months after procedure
|
|
Radiographic outcome
Time Frame: until 3 months after procedure
|
Compression rate
|
until 3 months after procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sang-Min Park, MD, Seoul National University Bundang Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 8, 2017
Primary Completion (Actual)
February 15, 2022
Study Completion (Actual)
March 20, 2022
Study Registration Dates
First Submitted
September 10, 2016
First Submitted That Met QC Criteria
September 10, 2016
First Posted (Estimate)
September 15, 2016
Study Record Updates
Last Update Posted (Actual)
January 5, 2023
Last Update Submitted That Met QC Criteria
January 3, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Decon_001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.